David Sinclair: AI Might Solve Longevity, GLP-1 Side Effects, and Longevity Investing | MOONSHOTS

30 Apr 2026 · 1 min
0:54

David Sinclair explains how AI can screen billions of molecules for anti-aging drugs and discusses GLP-1 drugs' benefits beyond weight loss. His father defied family history of early death and stroke, showing lifestyle can override genetics. Mindset matters most for longevity.

Chapters

More from Carlo

0:50
youtube.com

The 1999 Advice That Explains Today's AI Investment Boom

3w ago
1:21
youtube.com

Why the Future of Work Looks a Lot Like Iron Man

3w ago
1:21
youtube.com

One Simple Analogy for Why Automation Fears Are Overblown

3w ago
1:27
youtube.com

The Four Things Society Does Once Its Needs Are Met

3w ago
2:06:21
youtube.com

Robinhood's Vlad Tenev on Tokenizing Everything, OpenAI's 6 Misalignment Reports, Figure's Robot

3w ago
0:43
youtube.com

Why Leaving for a PhD Might Be a Mistake

3w ago
0:47
youtube.com

Why AGI Isn't the Finish Line

3w ago
1:10
youtube.com

The UK Still Can't Get the Model

3w ago
0:38
youtube.com

A Sword Duel Challenge to Elon and Jeff Bezos

3w ago
2:21:55
youtube.com

Frontier Labs Want to Slow Down, OpenAI Delays Its 2026 IPO, Anthropic Flags 5 Bioweapon Cases

4w ago
1:05
youtube.com

GDP Growth Is About to Look Like a Broken Compass

4w ago
See all content